1 |
Rufibach L, Berger K, Chakravorty S, Emmons S, Long L, Gibson G, Hegde M. Utilization of Targeted RNA-Seq for the Resolution of Variant Pathogenicity and Enhancement of Diagnostic Yield in Dysferlinopathy. JPM 2023;13:520. [DOI: 10.3390/jpm13030520] [Reference Citation Analysis]
|
2 |
Khattri RB, Batra A, Matheny M, Hart C, Henley-Beasley SC, Hammers D, Zeng H, White Z, Ryan TE, Barton E, Bernatchez P, Walter GA. Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy. NMR Biomed 2023;36:e4869. [PMID: 36331178 DOI: 10.1002/nbm.4869] [Reference Citation Analysis]
|
3 |
White Z, Sun Z, Sauge E, Cox D, Donen G, Pechkovsky D, Straub V, Francis GA, Bernatchez P. Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice. Skelet Muscle 2022;12:25. [PMID: 36447272 DOI: 10.1186/s13395-022-00308-6] [Reference Citation Analysis]
|
4 |
Wu X, Dong N, Yu L, Liu M, Jiang J, Tang T, Zhao H, Fang Q. Identification of immune-related features involved in Duchenne muscular dystrophy: A bidirectional transcriptome and proteome-driven analysis. Front Immunol 2022;13:1017423. [PMID: 36483550 DOI: 10.3389/fimmu.2022.1017423] [Reference Citation Analysis]
|
5 |
Moresi V, Renzini A, Cavioli G, Seelaender M, Coletti D, Gigli G, Cedola A. Functional Nutrients to Ameliorate Neurogenic Muscle Atrophy. Metabolites 2022;12:1149. [DOI: 10.3390/metabo12111149] [Reference Citation Analysis]
|
6 |
Israeli D, Vu Hong A, Corre G, Miagoux Q, Richard I. Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA Dysregulation. ncRNA 2022;8:48. [DOI: 10.3390/ncrna8040048] [Reference Citation Analysis]
|